Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns
At Advantage Living Center in Roseville, Michigan, Janelle prepares medication for a resident Photograph by Ali Lapetina
Letter |
14 April 2021

Letter from civil society organisations to US President Biden on TRIPS Waiver for COVID-19 medical tools

COVID-19
COVID19_Letter_TRIPSWaiverSignOnLetter_ENG_022621
Photograph by Ali Lapetina

Read, watch, share

The MSF treatment centre for COVID-19 patients at the Amirou Boubacar Diallo National Hospital in Niamey, Niger, has 50 beds, with the potential to accommodate up to 100 beds in case of a peak in patient numbers. The semi-permanent structure is completely autonomous to treat patients and limit the risk of transmission to the neighbouring hospital.
Letter
Letter |
18 April 2020
COVID-19

Letter to Trade Ministries and WTO: Stop all trade and investment treaty negotiations during the COVID-19 outbreak

Press release |
16 April 2020
COVID-19
United Kingdom

International organisations call on UK government to prevent Big Pharma profiteering from COVID-19

Letter
Letter |
15 April 2020
COVID-19
United Kingdom

A letter from civil society to the UK government: Impose access conditions for public funding in COVID-19 research

MSF Actions On Covid-19 Pandemic
Press release
Press release |
10 April 2020
COVID-19

MSF response on COVID-19 drugs pricing study by Andrew Hill et al.

ip_germany_patentoppositionprotest_peter_bauza_2018_msf243478_3800px
Letter
Letter |
09 April 2020
COVID-19

Letter to governments to revoke WTO ‘opt-out’ on compulsory licences

No monopolies - Acccess to COVID19 treatment/Brazil
Video
Video |
06 April 2020
COVID-19

No monopolies - Access to COVID-19 treatment

MSF donated 3.5 tonnes of personal protective equipment to health workers at the Wuhan Jinyintan Hospital in Hubei province.
Blog
Blog |
01 April 2020
COVID-19

A coronavirus vaccine must be affordable and accessible to all

MSF distributing tents and NFIs in Al habeet area.
Feature story
Feature story |
01 April 2020
COVID-19
Syria

MSF response to coronavirus disease COVID-19 - Syria

  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury